CassipaActive Ingredient(s): Buprenorphine + Naloxone
FDA Approved: * September 7, 2018
Pharm Company: * TEVA PHARMS USA INC
Category: Opioid Dependence
Buprenorphine is an opioid used to treat opioid use disorder, acute pain, and chronic pain. It can be used under the tongue (sublingual), in the cheek (buccal), by injection (intravenous and subcutaneous), as a skin patch (transdermal), or as an implant. For opioid use disorder, it is typically started when withdrawal symptoms have begun and for the first two days of treatment under direct observation of a health-care provider.[... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.